Advancement in Nanotheranostics for Effective Skin Cancer Therapy: State of the Art

Author:

Akhter Md. Habban1,Ahsan Mohamed Jawed2,Rahman Mahfoozur3,Anwar Siraj4,Rizwanullah Md.4

Affiliation:

1. Faculty of Pharmacy DIT University Dehradun, India

2. Department of Pharmaceutical Chemistry, College of Pharmacy, King Khalid University, Abha 62529, Saudi Arabia

3. Faculty of Health Sciences, Shalom Institute of Health and Allied Sciences (SIHAS) Sam Higginbottom University of Agriculture, Technology and Sciences Allahabad, 211007, Uttar Pradesh, India

4. Department of Pharmacology, School of Pharmaceutical Education and Research (SPER) Jamia Hamdard, New Delhi-110062, India

Abstract

: The skin cancer has become a leading concern worldwide as a result of high mortality rate. The treatment modality involves radiation therapy, chemotherapy or surgery. More often combination therapy of chemotherapeutic agents gives better solution over single chemotherapeutic agent. The Globocon report suggested that high incidence and mortality rate in skin cancer is growing day-to-day. This type of cancer is more prevalent in that area where a person is highly exposed to sunlight. The nanotechnology-based therapy is nowadays drawing attention and becoming a more important issue to be discussed. The nanotherapy of skin cancer is dealt with various approaches and strategies. The strategic based approaches imply nanoparticles targeting carcinoma cells, functionalized nanoparticles for specific targeting to cancer cells, receptor-mediated active targeting as nanoshells, nanostrutured lipid carriers, liposome, ethosome, bilosome, polymeric nanoparticle, nanosphere, dendrimers, carbon nanotubes, quantum dots, solid lipid nanoparticles and fullerenes which are highly efficient in specific killing of cancer cells. The passive targeting of chemotherapeutic agents is also helpful in dealing with carcinoma due to enhanced permeability and retention effect (EPR). : The article outlines nano-based therapy currently focused globally, and the outcomes of the therapy as well.

Publisher

Bentham Science Publishers Ltd.

Subject

Biomedical Engineering,Medicine (miscellaneous),Bioengineering

Reference92 articles.

1. Institut Jules Bordet. The History of Cancer. Accessed at xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.bordet.be/en/presentation/history/can-cer/cancer1.htm">www.bordet.be/en/presentation/history/can-cer/cancer1.htm on April 20, 2016.

2. Harris C.C.; p53 tumor suppressor gene: at the crossroads of molecular carcinogenesis, molecular epidemiology, and cancer risk assessment. Environ Health Perspect 1996,104(3)(Suppl. 3),435-439

3. Harris C.C.; Hollstein M.; Clinical implications of the p53 tumor-suppressor gene. N Engl J Med 1993,329(18),1318-1327

4. Ultraviolet (UV) radiation and skin cancer

5. Petersen B.; Wiegell S.R.; Wulf H.C.; Light protection of the skin after photodynamic therapy reduces inflammation: an unblinded randomized controlled study. Br J Dermatol 2014,171(1),175-180

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3